Massmutual Trust CO Fsb Crispr Therapeutics Ag Transaction History

Massmutual Trust CO Fsb

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 03, 2023	BUY	$45.39 - $59.0 $2,224 - $2,891	49 New	49 $2,000
Q1 2022 Apr 08, 2022	SELL	$53.19 - $79.24 $9,467 - $14,104	-178 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$70.09 - $111.29 $8,410 - $13,354	-120 Reduced 40.27%	178 $13,000
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $9,697 - $13,784	-88 Reduced 22.8%	298 $33,000
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $4,537 - $7,285	-45 Reduced 10.44%	386 $62,000
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $1,328 - $2,520	12 Added 2.86%	431 $53,000
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $16,252 - $35,338	204 Added 94.88%	419 $64,000
Q3 2020 Nov 13, 2020	SELL	$78.5 - $100.64 $1,884 - $2,415	-24 Reduced 10.04%	215 $18,000
Q4 2019 May 15, 2020	BUY	$36.68 - $73.13 $1,100 - $2,193	30 Added 14.35%	239 $15,000
Q3 2019 Nov 14, 2019	BUY	$40.99 - $52.56 $5,492 - $7,043	134 Added 178.67%	209 $9,000
Q4 2018 Feb 26, 2019	BUY	$22.73 - $42.34 $1,704 - $3,175	75 New	75 $2.14 Million

486

57.9M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.39B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

Stay updated on Massmutual Trust CO Fsb with notifications on news.